CCM
DNLI icon

Cinctive Capital Management’s Denali Therapeutics DNLI Stock Holding History

Cinctive Capital Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27,792
Closed -$404K – 423
2025
Q3 		$404K Buy
27,792
+3,482
+14% +$50K 0.02% 361
2025
Q2 		$340K Buy
+24,310
New +$342K 0.02% 335
2025
Q1 		– Sell
-130,445
Closed -$2.66M – 356
2024
Q4 		$2.66M Sell
130,445
-18,649
-13% -$477K 0.14% 194
2024
Q3 		$4.34M Buy
149,094
+36,771
+33% +$911K 0.24% 141
2024
Q2 		$2.61M Buy
+112,323
New +$2.16M 0.12% 220

Other funds holding DNLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return